OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production within Chinese hamster ovary (CHO) cells is a paramount challenge for the biopharmaceutical industry. Various strategies have been employed to antibody titer, comprising process parameter optimization, cell line development, and implementation of perfusion systems. Fine-tuning culture conditions